345 related articles for article (PubMed ID: 19288298)
21. Controlled release of hyaluronan oligomers from biodegradable polymeric microparticle carriers.
Hedberg EL; Shih CK; Solchaga LA; Caplan AI; Mikos AG
J Control Release; 2004 Nov; 100(2):257-66. PubMed ID: 15544873
[TBL] [Abstract][Full Text] [Related]
22. In vitro drug release behavior, mechanism and antimicrobial activity of rifampicin loaded low molecular weight PLGA-PEG-PLGA triblock copolymeric nanospheres.
Gajendiran M; Divakar S; Raaman N; Balasubramanian S
Curr Drug Deliv; 2013 Dec; 10(6):722-31. PubMed ID: 23701139
[TBL] [Abstract][Full Text] [Related]
23. Ketoprofen-poly(D,L-lactic-co-glycolic acid) microspheres: influence of manufacturing parameters and type of polymer on the release characteristics.
Gabor F; Ertl B; Wirth M; Mallinger R
J Microencapsul; 1999; 16(1):1-12. PubMed ID: 9972498
[TBL] [Abstract][Full Text] [Related]
24. Microparticles produced by the hydrogel template method for sustained drug delivery.
Lu Y; Sturek M; Park K
Int J Pharm; 2014 Jan; 461(1-2):258-69. PubMed ID: 24333903
[TBL] [Abstract][Full Text] [Related]
25. Encapsulation of PROLI/NO in biodegradable microparticles.
Jeh HS; Lu S; George SC
J Microencapsul; 2004 Feb; 21(1):3-13. PubMed ID: 14718181
[TBL] [Abstract][Full Text] [Related]
26. Investigation of the factors influencing the release rates of cyclosporin A-loaded micro- and nanoparticles prepared by high-pressure homogenizer.
Lee WK; Park JY; Yang EH; Suh H; Kim SH; Chung DS; Choi K; Yang CW; Park JS
J Control Release; 2002 Dec; 84(3):115-23. PubMed ID: 12468215
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and characterization of poly(lactic acid-co-glycolic acid) complex microspheres as drug carriers.
Wang F; Liu X; Yuan J; Yang S; Li Y; Gao Q
J Biomater Appl; 2016 Oct; 31(4):544-552. PubMed ID: 27368752
[TBL] [Abstract][Full Text] [Related]
28. In vitro degradation of nanoparticles prepared from polymers based on DL-lactide, glycolide and poly(ethylene oxide).
Zweers ML; Engbers GH; Grijpma DW; Feijen J
J Control Release; 2004 Dec; 100(3):347-56. PubMed ID: 15567501
[TBL] [Abstract][Full Text] [Related]
29. Effect of additives on the release of a model protein from PLGA microspheres.
Kang F; Singh J
AAPS PharmSciTech; 2001 Dec; 2(4):30. PubMed ID: 14727867
[TBL] [Abstract][Full Text] [Related]
30. Controlled release of transforming growth factor beta1 from biodegradable polymer microparticles.
Lu L; Stamatas GN; Mikos AG
J Biomed Mater Res; 2000 Jun; 50(3):440-51. PubMed ID: 10737887
[TBL] [Abstract][Full Text] [Related]
31. Pegylated recombinant human epidermal growth factor (rhEGF) for sustained release from biodegradable PLGA microspheres.
Kim TH; Lee H; Park TG
Biomaterials; 2002 Jun; 23(11):2311-7. PubMed ID: 12013178
[TBL] [Abstract][Full Text] [Related]
32. Preparation and characterization of a composite PLGA and poly(acryloyl hydroxyethyl starch) microsphere system for protein delivery.
Woo BH; Jiang G; Jo YW; DeLuca PP
Pharm Res; 2001 Nov; 18(11):1600-6. PubMed ID: 11758769
[TBL] [Abstract][Full Text] [Related]
33. Preparation and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(D,L-lactic-co-glycolic acid) microspheres using a double emulsion/solvent evaporation technique.
Karal-Yılmaz O; Serhatlı M; Baysal K; Baysal BM
J Microencapsul; 2011; 28(1):46-54. PubMed ID: 21171816
[TBL] [Abstract][Full Text] [Related]
34. Preparation of sustained release microparticles with improved initial release property.
Jung GY; Na YE; Park MS; Park CS; Myung PK
Arch Pharm Res; 2009 Mar; 32(3):359-65. PubMed ID: 19387579
[TBL] [Abstract][Full Text] [Related]
35. Poly(lactic acid)-poly(ethylene glycol) nanoparticles as new carriers for the delivery of plasmid DNA.
Perez C; Sanchez A; Putnam D; Ting D; Langer R; Alonso MJ
J Control Release; 2001 Jul; 75(1-2):211-24. PubMed ID: 11451511
[TBL] [Abstract][Full Text] [Related]
36. Protein instability in poly(lactic-co-glycolic acid) microparticles.
van de Weert M; Hennink WE; Jiskoot W
Pharm Res; 2000 Oct; 17(10):1159-67. PubMed ID: 11145219
[TBL] [Abstract][Full Text] [Related]
37. Erythropoietin loaded microspheres prepared from biodegradable LPLG-PEO-LPLG triblock copolymers: protein stabilization and in-vitro release properties.
Morlock M; Kissel T; Li YX; Koll H; Winter G
J Control Release; 1998 Dec; 56(1-3):105-15. PubMed ID: 9801434
[TBL] [Abstract][Full Text] [Related]
38. Water-free microencapsulation of proteins within PLGA microparticles by spray drying using PEG-assisted protein solubilization technique in organic solvent.
Mok H; Park TG
Eur J Pharm Biopharm; 2008 Sep; 70(1):137-44. PubMed ID: 18515053
[TBL] [Abstract][Full Text] [Related]
39. Towards the optimization of drug delivery to the cochlear apex: Influence of polymer and drug selection in biodegradable intracochlear implants.
Lehner E; Honeder C; Knolle W; Binder W; Scheffler J; Plontke SK; Liebau A; Mäder K
Int J Pharm; 2023 Aug; 643():123268. PubMed ID: 37488058
[TBL] [Abstract][Full Text] [Related]
40. Enhanced encapsulation and bioavailability of breviscapine in PLGA microparticles by nanocrystal and water-soluble polymer template techniques.
Wang H; Zhang G; Ma X; Liu Y; Feng J; Park K; Wang W
Eur J Pharm Biopharm; 2017 Jun; 115():177-185. PubMed ID: 28263795
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
